Skip to main content
HCPCS J7190 · Level II · Part B drug

J7190: factor VIII (Hemofil M, Koate), HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J7190

Billing unit
1 IU
Factor viii
ASP payment limit
$1.248
October 2026; +0.2% vs July 2026
Practitioner MUE
22000
MAI 1
OPPS status
SI K
APC 0925
NCCI exposure
no PTP pairs
Coverage articles
1
7 states

TL;DR

HCPCS J7190 is the Level II code for Factor viii (antihemophilic factor, human) per i.u., billed per 1 IU. The Medicare Part B ASP payment limit for October 2026 is $1.248 per billing unit, up 0.2% from July 2026. The practitioner MUE allows up to 22000 units per date of service (MAI 1), so a full 22000-unit day is $27,456.00 at the current limit. Under OPPS it carries status indicator K in APC 0925. J7190 is billed in units of 1 IU; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. Other HCPCS codes whose descriptor names factor VIII: J7188 (Obizur); J7192 (not otherwise specified (for products without their own code)); J7185 (Xyntha from Pfizer Inc); J7182 (Novoeight from Novo Nordisk, Inc); J7204 (Esperoct from Novo Nordisk, Inc); J7207 (Adynovate; pegylated). The ASP crosswalk maps 7 NDCs to it, sold as Hemofil M, Koate by Takeda Pharmaceuticals America, Inc., Kedrion Biopharma Inc. 1 Medicare coverage article lists the code across 7 states, including A56065.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J7190 at $1.248 per 1 IU for October 2026, derived from manufacturer average sales price plus 6%, compared with $1.246 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J7190
QuarterPayment limitPerCoinsurance
October 2026$1.2481 IU20%
July 2026$1.2461 IU—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 7 NDCs from 2 labelers to J7190. Report the NDC in the claim's drug segment and bill the number of J7190 units that equals the quantity administered divided by 1 IU; the last column gives units per full package.

NDCs that crosswalk to J7190
NDCDrug nameLabelerPackage sizeBilling units / package
00944-3940-02Hemofil MTakeda Pharmaceuticals America, Inc.1 × 11
00944-3942-02Hemofil MTakeda Pharmaceuticals America, Inc.1 × 11
00944-3944-02Hemofil MTakeda Pharmaceuticals America, Inc.1 × 11
00944-3946-02Hemofil MTakeda Pharmaceuticals America, Inc.1 × 11
76125-0257-25KoateKedrion Biopharma Inc1 × 11
76125-0663-50KoateKedrion Biopharma Inc1 × 11
76125-0679-12KoateKedrion Biopharma Inc1 × 11

Medically Unlikely Edits (MUE)

CMS publishes 2 MUE values for J7190. For practitioners the limit is 22000 units per date of service with adjudication indicator 1, a claim-line edit: units above the limit deny on that line, and documented separate services can be reported on another line with an appropriate modifier.

MUE values for J7190 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services220001 Line EditClinical: Data
Facility outpatient hospital220001 Line EditClinical: Data

MUE for J7190 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J7190 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J7190 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J7190 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

1 current Medicare Administrative Contractor article lists J7190 in their HCPCS tables, covering 7 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing J7190
ArticleTitleContractor(s)StatesRelated LCD
A56065Billing and Coding: Guidance for Anti-Inhibitor Coagulant Complex (AICC) National Coverage Determination (NCD) 110.3Palmetto GBAAL GA NC SC TN VA WV—

Diagnoses Medicare contractors cover for J7190

One billing and coding article attaches a covered diagnosis list to J7190: 14 distinct ICD-10-CM codes in all. The 14 below come first by how many of those articles cover them, then in the contractor's own order. The claim line is checked against the list of the contractor that processes it, and a diagnosis outside that list is denied as not medically necessary (CARC 50).

First 14 covered ICD-10-CM codes for J7190
ICD-10-CMDescription (FY2027)Articles covering
D68.2Hereditary deficiency of other clotting factors1 of 1
D66Hereditary factor VIII deficiency1 of 1
D68.01Von Willebrand disease, type 11 of 1
D68.020Von Willebrand disease, type 2A1 of 1
D68.021Von Willebrand disease, type 2B1 of 1
D68.022Von Willebrand disease, type 2M1 of 1
D68.023Von Willebrand disease, type 2N1 of 1
D68.03Von Willebrand disease, type 31 of 1
D68.04Acquired von Willebrand disease1 of 1
D68.09Other von Willebrand disease1 of 1
D67Hereditary factor IX deficiency1 of 1
D68.311Acquired hemophilia1 of 1
D68.318Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors1 of 1
D68.59Other primary thrombophilia1 of 1

Contractors split an article's diagnoses into numbered groups and say in each group's instructions which procedure codes it supports. Only the groups that apply to J7190 are counted here. The full list opens on the policy page with every group, the non-covered codes and the instructions.

Covered diagnosis lists that apply to J7190, by article
ArticleContractorGroups that applyCovered codes for J7190Full list
A56065Palmetto GBAone list for every code in the article14Open the list

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J7190 carries status indicator K and is assigned to APC 0925, with a published national unadjusted payment of $1.248. Status K means the drug is paid separately under OPPS at the ASP-based rate rather than packaged into the procedure.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J7190 carries payment indicator K2, which CMS defines as "Drugs, biologicals, and radiopharmaceuticals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate". The national ASC payment is $1.25 per 1 IU, paid only when the drug is furnished integral to a covered surgical procedure.

Common denials for J7190 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J7190

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J7190

What does HCPCS code J7190 describe?

J7190 is defined by CMS as "Factor viii (antihemophilic factor, human) per i.u.". Each billing unit represents 1 IU, so the units reported on the claim must equal the dose administered divided by that unit.

Is J7190 a CPT code?

No. J7190 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as factor VIII; CPT codes are five-character codes maintained by the AMA. On a Part B claim J7190 reports the drug itself in 1 IU units, and the administration is billed on its own line.

What is the Medicare reimbursement for J7190 in October 2026?

The ASP-based payment limit is $1.248 per 1 IU, with 20% beneficiary coinsurance. The July 2026 limit was $1.246. Commercial payers use their own fee schedules.

How many units of J7190 can be billed per day?

The practitioner Medically Unlikely Edit is 22000 units per date of service with adjudication indicator 1 (Line Edit). MAI 1 edits apply per claim line; units may be split across lines with an appropriate modifier when justified. CMS cites "Clinical: Data" as the rationale.

Which NDCs map to J7190?

The October 2026 ASP crosswalk lists 7 NDCs from 2 labelers: Hemofil M (Takeda Pharmaceuticals America, Inc.); Koate (Kedrion Biopharma Inc). For example NDC 00944-3940-02 (package size 1) equals 1 billing unit of J7190.

Does J7190 have NCCI bundling edits?

No active practitioner PTP pairs list J7190 as a column-1 or column-2 code in the v323r0 release.

J7190 vs J7188: what is the difference?

Both are HCPCS Level II codes whose descriptor names factor VIII. What sets J7188 apart: Obizur. J7190 is billed per 1 iu, limit $1.248, MUE 22000; J7188 is billed per 1 iu, limit $3.236, MUE 22000. Report the code whose descriptor matches the product and setting in the record.

J7190 vs J7192: what is the difference?

Both are HCPCS Level II codes whose descriptor names factor VIII. What sets J7192 apart: not otherwise specified (for products without their own code). J7190 is billed per 1 iu, limit $1.248, MUE 22000; J7192 is billed per 1 iu, limit $1.616, MUE 22000. Report the code whose descriptor matches the product and setting in the record.

Which Medicare coverage articles mention J7190?

1 current Billing and Coding Article in the Medicare Coverage Database lists J7190, covering 7 states: A56065 (Billing and Coding: Guidance for Anti-Inhibitor Coagulant Complex (AICC) National Coverage Determination (NCD) 110.3).

What diagnosis codes support J7190?

One Medicare billing and coding article lists 14 covered ICD-10-CM codes for J7190, for example D68.2 (Hereditary deficiency of other clotting factors); D66 (Hereditary factor VIII deficiency); D68.01 (Von Willebrand disease, type 1); D68.020 (Von Willebrand disease, type 2A); D68.021 (Von Willebrand disease, type 2B). Each contractor's list applies only in its own jurisdiction, so the claim must carry a code from the article of the contractor that processes it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.